Delivery Order SPE2DR25D3304-SPE2DR26F48B4
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (quantity: 30 count) under a firm fixed-price contract valued at $12,043.27. This non-competitive award, issued on December 9, 2025, with an ultimate completion date of December 10, 2025, represents a delivery order against AmerisourceBergen's larger indefinite delivery contract (IDC) with DLA Troop Support Medical. The work will be performed at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,215.65 to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Arimidex 1 mg tablets (30 count). The award is non-competitive and issued under a firm fixed-price delivery order contract type, with an ultimate completion date of November 17, 2025. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a delivery order valued at $34,247.33 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 8, 2025, with an ultimate completion date of December 9, 2025. This competitive award, utilizing firm fixed pricing with no set-aside designation, represents a direct fulfillment under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a $5,731.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This non-set-aside contract represents a routine pharmaceutical procurement fulfilling federal medical supply needs. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for military and...
- The Defense Logistics Agency awarded a $6,125.90 delivery order to AmerisourceBergen Drug Corp for 30-tablet units of Arimidex 1 mg tablets, with performance in Conshohocken, Pennsylvania and completion targeted for December 11, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed-price pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements with the federal government. AmerisourceBergen, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $10,006.96 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30 count). This firm fixed-price delivery order, awarded on October 24, 2025, with an ultimate completion date of October 27, 2025, represents a direct pharmaceutical procurement supporting federal medical supply requirements. The award was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for $4,726.80 to supply Arimidex 1 mg tablets in a 30-count package. The order, issued on December 5, 2025, with completion by December 8, 2025, represents a firm fixed-price delivery against AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. This contract was awarded without set-aside provisions through open competition. The place of performance is...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.29 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a $5,731.74 delivery order to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $5,378.10 for Arimidex 1 mg tablets (30-count packaging) with a completion date of November 14, 2025. This non-competitive, firm fixed-price delivery order was awarded on November 13, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor...
- SPE2DR25D3304Indefinite Delivery Contract
- SPE2DR25D3304-SPE2DR26F48B4Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,848.34 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) under a firm fixed price contract. The award was made on December 17, 2025, with an ultimate completion date of December 18, 2025, and represents a non-set-aside, competitively awarded procurement. The pharmaceutical products will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen leverages this prime IDC to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to the Defense Health Agency, U.S. Coast Guard, and other government medical programs. The contract demonstrates the company's established capability to meet military and federal healthcare pharmaceutical procurement requirements through competitive contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 12/16/25 |